Overview

Vietnam Plasma Fractionation Market is poised to value over USD 78.9 million by 2027 end at a CAGR of over 5.2% during the forecast period 2020 to 2027

FutureWise Market Research has instantiated a report that provides an intricate analysis of Vietnam Plasma Fractionation Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Vietnam Plasma Fractionation Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Vietnam Plasma Fractionation Market:
• BAXTER INTERNATIONAL INC.
• BIOTEST AG
• BIO PRODUCTS LABORATORY LTD.
• GETZ HEALTHCARE
• GRIFOLS SA
• KEDRION BIOPHARMA
• OCTAPHARMA
• NOVO NORDISK
• SANOVA HEALTHCARE
• SANQUIN BLOOD SUPPLY FOUNDATION
• TAKEDA PHARMACEUTICAL COMPANY LIMITED
(Note: The list of the major players will be updated with the latest market scenario and trends)

Vietnam Plasma Fractionation Market Segmentation:
By Product
• Albumin
• Immunoglobulins
• Subcutaneous Immunoglobulin (SCIG)
• Intravenous Immunoglobulin (IVIG)
• Coagulation Factor VIII
• Coagulation Factor IX

By Application  
• Neurology
• Hematology
• Immunology
• Critical Care
• Others

By End User
• Hospitals
• Clinical Research Laboratories

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Vietnam Plasma Fractionation Market By Product, By Application and By End User.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— Vietnam
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Vietnam Plasma Fractionation Market Variables, Trends & Scope
  4.1. Market LineProducts Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Vietnam Plasma Fractionation Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Vietnam Plasma Fractionation Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Vietnam Plasma Fractionation Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
  7.1. Albumin
  7.2. Immunoglobulins
  7.3. Subcutaneous Immunoglobulin (SCIG)
  7.4. Intravenous Immunoglobulin (IVIG)
  7.5. Coagulation Factor VIII
  7.6. Coagulation Factor IX

8. Vietnam Plasma Fractionation Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)  
  8.1. Neurology
  8.2. Hematology
  8.3. Immunology
  8.4. Critical Care
  8.5. Others

9. Vietnam Plasma Fractionation Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)  
  9.1. Hospitals
  9.2. Clinical Research Laboratories

15. Market Share Analysis and Competitive Landscape  
   15.1. Vietnam Landscape - Key Players, Revenue and Presence
   15.2. Vietnam Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   15.3. Vietnam Emerging Companies
   15.4. Vietnam- Market Share Analysis and Key Regional Players
   15.5. Vietnam Key Player - Growth Matrix

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   16.1. BAXTER INTERNATIONAL INC.
         16.1.1. Company Overview
         16.1.2. Product Portfolio
         16.1.3. SWOT Analysis
         16.1.4. Financial Overview
         16.1.5. Strategic Overview
   16.2. BIOTEST AG
         16.2.1. Company Overview
         16.2.2. Product Portfolio
         16.2.3. SWOT Analysis
         16.2.4. Financial Overview
         16.2.5. Strategic Overview
   16.3. BIO PRODUCTS LABORATORY LTD.
         16.3.1. Company Overview
         16.3.2. Product Portfolio
         16.3.3. SWOT Analysis
         16.3.4. Financial Overview
         16.3.5. Strategic Overview
   16.4. GETZ HEALTHCARE
         16.4.1. Company Overview
         16.4.2. Product Portfolio
         16.4.3. SWOT Analysis
         16.4.4. Financial Overview
         16.4.5. Strategic Overview
   16.5. GRIFOLS SA
         16.5.1. Company Overview
         16.5.2. Product Portfolio
         16.5.3. SWOT Analysis
         16.5.4. Financial Overview
         16.5.5. Strategic Overview          
   16.6. KEDRION BIOPHARMA
         16.6.1. Company Overview
         16.6.2. Product Portfolio
         16.6.3. SWOT Analysis
         16.6.4. Financial Overview
         16.6.5. Strategic Overview      
   16.7. OCTAPHARMA
         16.7.1. Company Overview
         16.7.2. Product Portfolio
         16.7.3. SWOT Analysis
         16.7.4. Financial Overview
         16.7.5. Strategic Overview
   16.8. NOVO NORDISK
         16.8.1. Company Overview
         16.8.2. Product Portfolio
         16.8.3. SWOT Analysis
         16.8.4. Financial Overview
         16.8.5. Strategic Overview
   16.9. SANOVA HEALTHCARE
         16.9.1. Company Overview
         16.9.2. Product Portfolio
         16.9.3. SWOT Analysis
         16.9.4. Financial Overview
         16.9.5. Strategic Overview
   16.10.SANQUIN BLOOD SUPPLY FOUNDATION
         16.10.1. Company Overview
         16.10.2. Product Portfolio
         16.10.3. SWOT Analysis
         16.10.4. Financial Overview
         16.10.5. Strategic Overview
   16.11.TAKEDA PHARMACEUTICAL COMPANY LIMITED
         16.11.1. Company Overview
         16.11.2. Product Portfolio
         16.11.3. SWOT Analysis
         16.11.4. Financial Overview
         16.11.5. Strategic Overview

17. Pre and Post COVID-19 Impact
   17.1. Positive influence on the healthcare industry
   17.2. The financial disruption of the manufacturing sector
   17.3. Impact of COVID-19 on emerging companies
   17.4. Significant mandates in the healthcare regulations initiated by administrations
   17.5. The overall economic slowdown of the developing and developed nations

18. FutureWise SME Key Takeaway Points for Client

Tables

Figures